Search
Ty800
go.drugbank.com/drugs/DB04989InvestigationalThe Ty800 vaccine was developed using genetic techniques to delete specific genes known to be essential to the virulence of <i>S. typhi</i>. It is being developed by AVANT Immunotherapeutics, Inc.
AN-9
go.drugbank.com/drugs/DB05103InvestigationalIt shows greater potency than BA at inducing malignant cell differentiation and tumor growth inhibition and has demonstrated more favorable toxicological, pharmacological, and pharmaceutical properties
Telenzepine
go.drugbank.com/drugs/DB19508InvestigationalTelenzepine has a monoisotopic molecular weight of 370.15 Da.
Setileuton
go.drugbank.com/drugs/DB19550InvestigationalSetileuton has a monoisotopic molecular weight of 463.12 Da.
Felezonexor
go.drugbank.com/drugs/DB21067InvestigationalFelezonexor has a monoisotopic molecular weight of 419.12 Da.
Ledaborbactam etzadroxil
go.drugbank.com/drugs/DB21455InvestigationalLedaborbactam etzadroxil has a monoisotopic molecular weight of 391.18 Da.
Edaxeterkib
go.drugbank.com/drugs/DB21490InvestigationalEdaxeterkib has a monoisotopic molecular weight of 469.22 Da.
Azetukalner
go.drugbank.com/drugs/DB21551InvestigationalAzetukalner has a monoisotopic molecular weight of 368.23 Da.
Icovamenib
go.drugbank.com/drugs/DB21669InvestigationalIcovamenib has a monoisotopic molecular weight of 566.28 Da.
8-azaguanine
go.drugbank.com/drugs/DB01667ExperimentalIt functions as an antimetabolite and is easily incorporated into ribonucleic acids.